In an increasingly complex clinical research environment, safeguarding patient safety while ensuring high-quality data has become more critical than ever. A new strategic alliance between Verified Clinical Trials (VCT) and Chubb aims to address both priorities head-on by introducing a more proactive, integrated approach to clinical trial risk management.
This collaboration brings together two complementary capabilities: VCT’s advanced subject registry technology and Chubb’s global expertise in clinical trial insurance and risk mitigation. The result is a unified effort to help sponsors, contract research organizations (CROs), and research sites better protect study participants while improving the overall reliability and success of clinical trials.
A Shift Toward Proactive Risk Management
Clinical trials have long faced a persistent and often underrecognized challenge: the inability to fully verify a participant’s prior study involvement. This gap can lead to duplicate or undisclosed enrollment, increasing the risk of adverse events, compromising data integrity, and potentially jeopardizing entire studies.
Through this alliance, VCT’s real-time subject verification system becomes part of a broader risk management framework. By identifying potential protocol violations at the screening stage, stakeholders can take early action—reducing downstream complications that are often costly and difficult to resolve.
Why This Matters for Clinical Research
This collaboration is designed to deliver meaningful benefits across the clinical trial ecosystem:
Strong protection for research participants by helping prevent overlapping study participation and reducing risks such as drug interactions and safety events.
Higher confidence in data quality through cleaner datasets that support more reliable analysis, better decision-making, and stronger regulatory submissions.
Improved protocol compliance by ensuring participants meet eligibility criteria and helping maintain study integrity.
Reduced operational and financial risk by mitigating costs and liabilities associated with protocol deviations, data discrepancies, and regulatory challenges.
Greater likelihood of trial success by supporting studies that are better controlled and less prone to disruption.
Broader impact on public health by contributing to the development of safer, more effective therapies for patients and communities worldwide.
Complementary Strengths Driving Industry Impact
Chubb is a recognized leader in clinical trial insurance, supporting life sciences companies ranging from emerging innovators to global pharmaceutical organizations. Its insurance solutions are designed to address risks related to adverse events, regulatory exposure, and operational disruptions.
Verified Clinical Trials enhances this framework with a unique layer of prevention. Its global subject registry is widely used to detect duplicate enrollment and other protocol violations before they impact trial outcomes.
Together, these capabilities create a more comprehensive model that not only responds to risk but actively works to prevent it.
Leadership Perspective
Leaders from both organizations emphasize that this alliance represents a broader evolution in how the industry approaches clinical trial oversight.
Dr. Mitchell Efros, Co-Founder and CEO of Verified Clinical Trials, underscores the importance of prioritizing both safety and data integrity to ensure successful research outcomes. He notes that integrating oversight earlier in the trial process can provide meaningful benefits across the entire ecosystem.
Chubb’s leadership highlights the longstanding challenge of verifying participant eligibility and views this collaboration as a practical solution to an issue that has historically lacked visibility and effective tools.
Kerri Weingard, Co-Founder and Global COO of Verified Clinical Trials, describes the alliance as a shift from reactive to proactive safeguards, combining technology and risk expertise to create a more secure and transparent research environment.
Advancing the Future of Clinical Trials
As clinical trials continue to grow in scale and complexity, collaboration across disciplines is becoming essential. This alliance between Verified Clinical Trials and Chubb demonstrates the value of combining technology, data, and risk management into a cohesive strategy.
By aligning their strengths, both organizations are helping establish a new standard where participant safety, data integrity, and operational success are interconnected priorities.
For sponsors, CROs, and research sites, this approach provides a clearer path forward. For patients, it offers something even more important: greater confidence in the safety and effectiveness of the therapies being developed.